View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
June 16, 2021

LetsGetChecked’s Covid-19 test gets FDA authorisation for children

Adults can obtain the sample from children aged two to 11 years and supervise self-collection in those aged 12 to 18 years.

The US Food and Drug Administration (FDA) has expanded the Emergency Use Authorisation (EUA) of LetsGetChecked’s Covid-19 test for at-home use to children aged two years and above.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

As per the latest authorisation, adults can obtain the nasal swab sample for the test from children aged two to 11 years, while those aged 12 to 18 years can self-collect the sample at home under adult supervision.

The EUA expansion will increase access to home-based testing for minors, enabling a broader population to assess their health status and helping to contain the Covid-19 spread among children.

In May last year, the FDA granted EUA to the LetsGetChecked Covid-19 home collection test.

The FDA updated the EUA for direct-to-consumer purchase of the test, without requiring a prescription, this March.

The polymerase chain reaction lab-based test can deliver results within 24 to 72 hours on receiving the sample by the lab.

As compared to serology tests, which check for the presence of antibodies or viral antigens, the LetsGetChecked test analyses the presence or absence of SARS-CoV-2 viral RNA.

LetsGetChecked founder and CEO Peter Foley said: “As we begin to resume pre-pandemic activities, testing young people for active coronavirus infections using gold-standard molecular diagnostic analysis is essential and critical for public health.

“With the EUA of this new indication, we have the opportunity to support an even larger portion of the American population with testing to increase confidence during the back-to-school season and beyond.”

The test is available at a price range starting from $89 per test.

A virtual care company, LetsGetChecked offers direct access to telehealth services, pharmacy and at-home diagnostics for sexual health, cholesterol, diabetes, thyroid and Covid-19, among others.

Founded in 2015, the company has operations across the US and in several European Union countries.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network